Carisma Therapeutics Inc - CARM Operating Margin

carismatx.com - graphic logo of issuer CARM

Carisma Therapeutics (CARM) is facing financial losses and complexities in the development of cell-based therapies. High barriers to entry are established by gene modification patents and the requirement for a robust scientific foundation. A flawless reputation as a leader in solid tumor therapy attracts major partners. The operating margin trend illustrates the business recovery process, and -428.30 shows the current value of this metric.

Carisma Tx (CARM): Profitability of Operations from 04/28/2023 to 10/25/2025

Analytical breakdowns and data insights for company Carisma Therapeutics (CARM)

- price and consensus price forecast:
Fundamental company valuation:Carisma Therapeutics
Finished products of Carisma Tx

Operating margin measures cost management efficiency by determining the share of profit from core operations before taxes and interest relative to total revenue. By analyzing operating margin trends on GURU.Markets, an investor assesses the resilience of the Carisma Therapeutics (CARM) business model, where a strong scientific reputation in solid tumor therapy should translate into optimized operating expenses and future profitability.

Direct competitors

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Margin KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operating Profit Margin|PVLA: Operating Sales Margin|Operating Profit Margin SVRA|RIGL: Operating Margin|Return on Sales by Operating Profit ANAB|ATXS (Astria Corp) - Operating Margin|Return on Sales by Operating Profit ENGN (enGene Bio)|Operating Margin RAPT|Profitability of Operations Aerovate Therapeutics|Operating Profitability Aclaris Therapeutics Inc. ACRS|Profitability of Operations Kyverna Therapeutics Inc. (KYTX)|TLSA - Operating Profitability|CABA: Operating Profitability|VTYX (Ventyx Biosciences, Inc.) - Operating Sales Margin|THTX - Profitability of Operations|AVTX (avalotx.com) - Operating Margin|Operating Return on Sales Eledon Pharmaceuticals Inc. ELDN|Operating Margin AGEN|CLYM (Climb Bio, Inc.) - Operating Profit Rate|Operating Profitability zurabio.com ZURA|ATYR - Operating Sales Margin|Adagene Inc - Operating Margin|ImageneBio (IMA) - Operating Sales Margin|Shattuck Therapeutics (STTK) - Operating Profitability|Operating Return on Sales Equillium Inc (EQ)|Operating Sales Margin CNTB|Return on Sales by Operating Profit IMUX (Immunic, Inc.)|Operating Profitability Atara Biotherapeutics, Inc. (ATRA)|IFRX - Operating Return on Sales|Profitability of Operations XFOR|Profitability of Operations Adicet (ACET)|CELU - Operating Profitability|INMB (INmune Bio, Inc.) - Return on Sales by Operating Profit|BRNS: Operating Margin|Kezar Life Sciences Inc. (KZR) - Operating Margin|Operating Profitability SAB Biotherapeutics Inc|Operating Margin Akari Therapeutics, Plc|Operating Profitability Enlivex Therapeutics Ltd (ENLV)|QTTB - Operating Return on Sales|Operating Margin GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Operating Return on Sales|iBio Corporation - Operating Margin|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com